Target intelligence / Profile preview

Intestinal potassium channel (K+ channel)

Target
K+ channel
Molecular classification
Ion channel
01

Overview

Intestinal potassium (K+) channels represent a diverse group of ion channels, including KCa3.1, KCNQ1, and BK channels, that are expressed in the epithelial and smooth muscle cells of the gastrointestinal tract. These channels are fundamental to intestinal physiology, as they maintain the negative membrane potential required to drive the secretion of chloride ions and water into the intestinal lumen (He et al., 2011, PubMed: 21835910). In the epithelium, basolateral K+ recycling via channels like KCa3.1 and KCNQ1/KCNE3 is essential for sustained fluid secretion (Devor et al., 1996, PubMed: 8939873). Dysregulation of these channels is a hallmark of various gastrointestinal pathologies; for instance, their overactivation is a primary driver of secretory diarrhea, while their dysfunction can contribute to impaired motility and inflammatory bowel disease. Consequently, these channels are significant therapeutic targets, with inhibitors like Senicapoc being investigated for their ability to reduce excessive fluid loss in diarrheal conditions (Ataga et al., 2008, PubMed: 18216214). However, targeting these channels requires high specificity to avoid systemic side effects, such as cardiac arrhythmias or neurological disturbances, due to the widespread expression of K+ channel homologs in other tissues.

Other names
Enteric potassium channelsGastrointestinal potassium channelsKCa3.1 (Intermediate-conductance calcium-activated potassium channel)KCNQ1 (Voltage-gated potassium channel subfamily Q member 1)BK channels (Large-conductance calcium-activated potassium channels)IK channels
02

Mechanism of action

Modulation of potassium ion efflux to regulate the electrochemical gradient for transepithelial fluid transport and smooth muscle contractility.

03

Biological functions

Electrolyte transportFluid secretionMembrane potential regulationSmooth muscle contractionPotassium recycling
04

Disease associations

DiarrheaConstipationInflammatory bowel diseaseIrritable bowel syndrome
05

Safety considerations

Systemic electrolyte imbalanceOff-target cardiac effectsOff-target neuronal effects
06

Interacting drugs

Senicapoc

3 more in the full profile.

07

Biomarkers

Stool osmotic gapFecal electrolyte concentrationTransepithelial potential difference

Beyond the preview

Go deeper on Intestinal potassium channel (K+ channel).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal potassium channel (K+ channel).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call